Rachel is Professor of Health Economics at the University of Manchester and a UK registered pharmacist. She has brought in £28million funding in applied health economics research which has influenced health policy and practice in the UK and elsewhere, completed a Harkness Fellowship at Harvard Medical School and has authored two books and over 150 research publications. Research themes include medicines safety and adherence. She has experience of working closely with the NHS and patient stakeholders in the development and evaluation of a pharmacist/IT complex intervention in primary care, PINCER (RCT, regional and national roll-out), the Electronic Prescription Service and the New Medicine Service. She is currently leading work to assess the economic impact of reductions in harm anticipated from the new NHS medicines interoperability information standards. She is chair of the Selection Panel for the HEE-NIHR Integrated Clinical and Practitioner Academic Programme. She is a member of the editorial board for Pharmacoeconomics and the International Journal of Pharmacy Practice, and has just completed two terms as chair of the Pharmacy Research UK Scientific Advisory Panel. She is a PRUK trustee. She has been member of a NICE technology appraisal committee since 2006.